SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

EDAP Reports Exclusive Distribution Deal With AB Medica, No Terms Disclosed

EDAP TMS SA (NASDAQ:EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive distribution agreement with AB Medica, a leading

· 11/17/2020 08:08

EDAP TMS SA (NASDAQ:EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive distribution agreement with AB Medica, a leading distribution of medical technologies across Italy.

Marc Oczachowski, Chairman and Chief Executive Officer of EDAP, commented: “We are very pleased to partner with AB Medica, a widely recognized leader in Italy for the distribution of cutting-edge medical technologies. This is clearly a step forward for EDAP in its HIFU adoption and commercialization program in Europe, as Italy is the fourth largest market for medical devices. Notably, AB Medica had already been distributing ExactVu, so they are familiar with our product line and have been able to incorporate Focal One very quickly. AB Medica also has extensive experience in the distribution of robotic prostate surgery solutions, so they are the perfect fit for us. We look forward to a very successful partnership.”

Filippo Pacinotti, Business Director of AB Medica, stated: “We are thrilled to have entered into this distribution agreement with EDAP, which is already a highly recognized name in Italy. This partnership will not only see us strengthen our presence in high definition ultrasound with ExactVu, but will also give us the opportunity to become a reference point in lithotripsy and HIFU, rounding out what will be an outstanding urology product portfolio. We are confident that we will meet EDAP’s expectations, and we are eager to start this new adventure with great enthusiasm.”